Literature DB >> 20608745

Crystal structure of a complex between the Actinomadura R39 DD-peptidase and a peptidoglycan-mimetic boronate inhibitor: interpretation of a transition state analogue in terms of catalytic mechanism.

Liudmila Dzhekieva1, Mathieu Rocaboy, Frédéric Kerff, Paulette Charlier, Eric Sauvage, R F Pratt.   

Abstract

The Actinomadura R39 DD-peptidase is a bacterial low molecular weight class C penicillin-binding protein. It has previously been shown to catalyze hydrolysis and aminolysis of small D-alanyl-D-alanine terminating peptides, especially those with a side chain that mimics the amino terminus of the stem peptide precursor to the bacterial cell wall. This paper describes the synthesis of (D-alpha-aminopimelylamino)-D-1-ethylboronic acid, designed to be a peptidoglycan-mimetic transition state analogue inhibitor of the R39 DD-peptidase. The boronate was found to be a potent inhibitor of the peptidase with a K(i) value of 32 +/- 6 nM. Since it binds some 30 times more strongly than the analogous peptide substrate, the boronate may well be a transition state analogue. A crystal structure of the inhibitory complex shows the boronate covalently bound to the nucleophilic active site Ser 49. The aminopimelyl side chain is bound into the site previously identified as specific for this moiety. One boronate oxygen is held in the oxyanion hole; the other, occupying the leaving group site of acylation or the nucleophile site of deacylation, appears to be hydrogen-bonded to the hydroxyl group of Ser 298. The Ser 49 oxygen appears to be hydrogen bonded to Lys 52. If it is assumed that this structure does resemble a high-energy tetrahedral intermediate in catalysis, it seems likely that Ser 298 participates as part of a proton transfer chain initiated by Lys 52 or Lys 410 as the primary proton donor/acceptor. The structure, therefore, supports a particular class of mechanism that employs this proton transfer device.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608745     DOI: 10.1021/bi100757c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  A computational evaluation of the mechanism of penicillin-binding protein-catalyzed cross-linking of the bacterial cell wall.

Authors:  Qicun Shi; Samy O Meroueh; Jed F Fisher; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2011-03-18       Impact factor: 15.419

2.  Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in β-lactam resistance.

Authors:  Jeffrey D Smith; Malika Kumarasiri; Weilie Zhang; Dusan Hesek; Mijoon Lee; Marta Toth; Sergei Vakulenko; Jed F Fisher; Shahriar Mobashery; Yu Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

3.  Structure guided development of potent reversibly binding penicillin binding protein inhibitors.

Authors:  Esther C Y Woon; Astrid Zervosen; Eric Sauvage; Katie J Simmons; Matej Zivec; Steven R Inglis; Colin W G Fishwick; Stanislav Gobec; Paulette Charlier; André Luxen; Christopher J Schofield
Journal:  ACS Med Chem Lett       Date:  2011-01-11       Impact factor: 4.345

4.  Crossover inhibition as an indicator of convergent evolution of enzyme mechanisms: a β-lactamase and a N-terminal nucleophile hydrolase.

Authors:  S A Adediran; G Lin; R B Pelto; R F Pratt
Journal:  FEBS Lett       Date:  2012-10-23       Impact factor: 4.124

5.  Inhibition of DD-peptidases by a specific trifluoroketone: crystal structure of a complex with the Actinomadura R39 DD-peptidase.

Authors:  Liudmila Dzhekieva; S A Adediran; Raphael Herman; Frédéric Kerff; Colette Duez; Paulette Charlier; Eric Sauvage; R F Pratt
Journal:  Biochemistry       Date:  2013-03-13       Impact factor: 3.162

6.  Protonation states of active-site lysines of penicillin-binding protein 6 from Escherichia coli and the mechanistic implications.

Authors:  Malika Kumarasiri; Weilie Zhang; Qicun Shi; Jed F Fisher; Shahriar Mobashery
Journal:  Proteins       Date:  2014-02-06

7.  High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes.

Authors:  Hector Newman; Alen Krajnc; Dom Bellini; Charles J Eyermann; Grant A Boyle; Neil G Paterson; Katherine E McAuley; Robert Lesniak; Mukesh Gangar; Frank von Delft; Jürgen Brem; Kelly Chibale; Christopher J Schofield; Christopher G Dowson
Journal:  J Med Chem       Date:  2021-07-31       Impact factor: 8.039

8.  Crystal structure of penicillin-binding protein 3 (PBP3) from Escherichia coli.

Authors:  Eric Sauvage; Adeline Derouaux; Claudine Fraipont; Marine Joris; Raphaël Herman; Mathieu Rocaboy; Marie Schloesser; Jacques Dumas; Frédéric Kerff; Martine Nguyen-Distèche; Paulette Charlier
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

9.  Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases.

Authors:  Liudmila Dzhekieva; S A Adediran; R F Pratt
Journal:  Biochemistry       Date:  2014-10-10       Impact factor: 3.162

Review 10.  Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New Antibacterials.

Authors:  Eric Sauvage; Mohammed Terrak
Journal:  Antibiotics (Basel)       Date:  2016-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.